Postauthorization safety surveillance study of antihaemophilic factor (recombinant) reconstituted in 2 mL sterile water for injection in children with haemophilia A

INTRODUCTION: Antihaemophilic factor (recombinant) (rAHF; ADVATE(®)) is approved for prophylaxis and treatment of bleeding in children and adults with haemophilia A. Reconstitution in 2 mL sterile water for injection instead of 5 mL allows for a 60% reduction in infusion volume and administration ti...

Descripción completa

Detalles Bibliográficos
Autores principales: Motwani, Jayashree, Guillet, Benoit, Blatny, Jan, Schilling, Freimut H., Wibaut, Bénédicte, Goldstine, Jimena, Nagy, Andras, Doralt, Jennifer, Engl, Werner, Tangada, Srilatha, Spotts, Gerald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383916/
https://www.ncbi.nlm.nih.gov/pubmed/32338433
http://dx.doi.org/10.1111/hae.13997

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383916/
https://www.ncbi.nlm.nih.gov/pubmed/32338433
http://dx.doi.org/10.1111/hae.13997

Ejemplares similares